Nonetheless, potential benefits of GLP-1RAs on aspects of NUD may be observed in some persons taking these agents for on-label indications (e.g., obesity, T2DM)
Lets compare the landmark phase studies for both molecules
Schneeweiss S, Avorn J (2005) A review of uses of health care utilization databases for epidemiologic research on therapeutics
Mounjaro (Tirzepatide): Dual-Receptor Action Mounjaro works on both GLP-1 receptors (like Ozempic) and adds GIP receptors into the mix
Weakness or Unsteadiness : Feeling weak, like your muscles cant support you, or being unable to stand or walk properly, indicates that fainting may follow
Overall, the addition of L-81 to Liposyn did not reduce the cumulative GLP-1 output to the same levels as saline controls, whereas GIP secretion was abolished (Lu et al., 2012)